INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity
CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products.
Image Credit: INTEGRA Biosciences
The company is well-known for its flagship product – the HuProt™ Human Proteome Microarray – and has since expanded its portfolio to include a catalogue of over 2,000 monoclonal antibodies designed to accelerate research and advance discoveries that improve human health. Edisa Albino, a senior project manager and operations development scientist at CDI, explained: “Monoclonal antibodies are frequently used in life sciences research, yet many of the molecules currently available commercially aren’t very specific. Each of our monoclonal antibodies is monospecific, and has been extensively validated using flow cytometry, characte
Puerto-rico
United-states
Zizers
Switzerland-general
Switzerland
Edisa-albino
Human-proteome-microarray
Fatigue
Pipetting
Antibodies
Biotechnology
Cell
Mar 06 2021 Read 2003 Times
Integra Biosciences AG has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes. This is the tenth straight year of sales growth for this hidden champion from the Chur Rhine Valley.
Reporting sales of CHF130 in 2020, it has been the best year ever for Integra Biosciences AG. The 73% increase from 2019 was driven by huge demand worldwide for the laboratory instruments it develops and manufactures in Zizers. The company saw particular growth in the sales of pipettes and pipette tips that are being used in diagnostics and research to combat COVID-19. “We are pleased with this excellent performance, and proud of our work contributing towards overcoming the pandemic,” said Urs Hartmann, who has led Integra Biosciences as its CEO since January 2020. Sales have risen consistently since 2010, at a mean annual rate of 23%, and the company won an average of five
Chur
Graubusz
Switzerland
Zizers
Switzerland-general
Integra-biosciences
Integration-program
Chur-rhine
Pintegra
Sales
Company
Biosciences